Promotion of mental health in young adults via mobile phone app: study protocol of the ECoWeB (emotional competence for well-being in Young adults) cohort multiple randomised trials.
Depression
Emotional competence
Mobile-health prevention
Personalization
Randomised controlled trial
Rumination
Well-being
Young people
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
22 09 2020
22 09 2020
Historique:
received:
24
07
2020
accepted:
03
09
2020
entrez:
23
9
2020
pubmed:
24
9
2020
medline:
30
12
2020
Statut:
epublish
Résumé
Promoting well-being and preventing poor mental health in young people is a major global priority. Building emotional competence (EC) skills via a mobile app may be an effective, scalable and acceptable way to do this. However, few large-scale controlled trials have examined the efficacy of mobile apps in promoting mental health in young people; none have tailored the app to individual profiles. The Emotional Competence for Well-Being in Young Adults cohort multiple randomised controlled trial (cmRCT) involves a longitudinal prospective cohort to examine well-being, mental health and EC in 16-22 year olds across 12 months. Within the cohort, eligible participants are entered to either the PREVENT trial (if selected EC scores at baseline within worst-performing quartile) or to the PROMOTE trial (if selected EC scores not within worst-performing quartile). In both trials, participants are randomised (i) to continue with usual practice, repeated assessments and a self-monitoring app; (ii) to additionally receive generic cognitive-behavioural therapy self-help in app; (iii) to additionally receive personalised EC self-help in app. In total, 2142 participants aged 16 to 22 years, with no current or past history of major depression, bipolar disorder or psychosis will be recruited across UK, Germany, Spain, and Belgium. Assessments take place at baseline (pre-randomisation), 1, 3 and 12 months post-randomisation. Primary endpoint and outcome for PREVENT is level of depression symptoms on the Patient Health Questionnaire-9 at 3 months; primary endpoint and outcome for PROMOTE is emotional well-being assessed on the Warwick-Edinburgh Mental Wellbeing Scale at 3 months. Depressive symptoms, anxiety, well-being, health-related quality of life, functioning and cost-effectiveness are secondary outcomes. Compliance, adverse events and potentially mediating variables will be carefully monitored. The trial aims to provide a better understanding of the causal role of learning EC skills using interventions delivered via mobile phone apps with respect to promoting well-being and preventing poor mental health in young people. This knowledge will be used to develop and disseminate innovative evidence-based, feasible, and effective Mobile-health public health strategies for preventing poor mental health and promoting well-being. ClinicalTrials.gov ( www.clinicaltrials.org ). Number of identification: NCT04148508 November 2019.
Sections du résumé
BACKGROUND
Promoting well-being and preventing poor mental health in young people is a major global priority. Building emotional competence (EC) skills via a mobile app may be an effective, scalable and acceptable way to do this. However, few large-scale controlled trials have examined the efficacy of mobile apps in promoting mental health in young people; none have tailored the app to individual profiles.
METHOD/DESIGN
The Emotional Competence for Well-Being in Young Adults cohort multiple randomised controlled trial (cmRCT) involves a longitudinal prospective cohort to examine well-being, mental health and EC in 16-22 year olds across 12 months. Within the cohort, eligible participants are entered to either the PREVENT trial (if selected EC scores at baseline within worst-performing quartile) or to the PROMOTE trial (if selected EC scores not within worst-performing quartile). In both trials, participants are randomised (i) to continue with usual practice, repeated assessments and a self-monitoring app; (ii) to additionally receive generic cognitive-behavioural therapy self-help in app; (iii) to additionally receive personalised EC self-help in app. In total, 2142 participants aged 16 to 22 years, with no current or past history of major depression, bipolar disorder or psychosis will be recruited across UK, Germany, Spain, and Belgium. Assessments take place at baseline (pre-randomisation), 1, 3 and 12 months post-randomisation. Primary endpoint and outcome for PREVENT is level of depression symptoms on the Patient Health Questionnaire-9 at 3 months; primary endpoint and outcome for PROMOTE is emotional well-being assessed on the Warwick-Edinburgh Mental Wellbeing Scale at 3 months. Depressive symptoms, anxiety, well-being, health-related quality of life, functioning and cost-effectiveness are secondary outcomes. Compliance, adverse events and potentially mediating variables will be carefully monitored.
CONCLUSIONS
The trial aims to provide a better understanding of the causal role of learning EC skills using interventions delivered via mobile phone apps with respect to promoting well-being and preventing poor mental health in young people. This knowledge will be used to develop and disseminate innovative evidence-based, feasible, and effective Mobile-health public health strategies for preventing poor mental health and promoting well-being.
TRIAL REGISTRATION
ClinicalTrials.gov ( www.clinicaltrials.org ). Number of identification: NCT04148508 November 2019.
Identifiants
pubmed: 32962684
doi: 10.1186/s12888-020-02857-w
pii: 10.1186/s12888-020-02857-w
pmc: PMC7510072
doi:
Banques de données
ClinicalTrials.gov
['NCT04148508']
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
458Subventions
Organisme : H2020 European Research Council
ID : 754657
Pays : International
Références
Behav Res Methods. 2016 Dec;48(4):1383-1392
pubmed: 26416137
Curr Psychiatry Rep. 2018 May 19;20(6):44
pubmed: 29779065
J Child Psychol Psychiatry. 2018 Feb;59(2):160-170
pubmed: 28921523
Child Dev. 2011 Jan-Feb;82(1):405-32
pubmed: 21291449
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
J Med Internet Res. 2013 Nov 15;15(11):e247
pubmed: 24240579
Health Technol Assess. 2015 Sep;19(73):1-124
pubmed: 26379122
Depress Anxiety. 2017 Jun;34(6):518-525
pubmed: 28504859
Nature. 2019 Sep;573(7774):364-369
pubmed: 31391586
Psychiatr Serv. 2011 Mar;62(3):255-63
pubmed: 21363896
Science. 2009 Dec 4;326(5958):1410-2
pubmed: 19965759
Emot Rev. 2016 Jul;8(3):258-268
pubmed: 27594904
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Behav Res Ther. 2017 Mar;90:123-136
pubmed: 28049069
Behav Res Ther. 1999 Jun;37(6):503-31
pubmed: 10372466
Br J Psychiatry. 2007 Dec;191:521-7
pubmed: 18055956
Psychol Assess. 2014 Jun;26(2):666-72
pubmed: 24295238
Br J Psychiatry. 2002 May;180:461-4
pubmed: 11983645
JAMA Psychiatry. 2017 May 1;74(5):437-438
pubmed: 28384700
J Youth Adolesc. 2015 Jan;44(1):90-113
pubmed: 25115460
Psychol Bull. 2008 Mar;134(2):163-206
pubmed: 18298268
Clin Trials. 2012 Aug;9(4):396-407
pubmed: 22752633
Cochrane Database Syst Rev. 2011 Dec 07;(12):CD003380
pubmed: 22161377
World Psychiatry. 2017 Oct;16(3):287-298
pubmed: 28941113
Pharmacoeconomics. 1996 Nov;10(5):460-6
pubmed: 10172868
Psychol Bull. 2011 Nov;137(6):940-58
pubmed: 21728399
BMJ. 2000 Apr 29;320(7243):1197-200
pubmed: 10784550
J Res Pers. 2009 Dec 1;43(6):1064-1072
pubmed: 20160869
J Child Psychol Psychiatry. 2018 Aug;59(8):831-844
pubmed: 29052837
Annu Rev Clin Psychol. 2015;11:379-405
pubmed: 25581242
J Nonverbal Behav. 2018 Jun;42(2):155-178
pubmed: 29527080
J Abnorm Psychol. 2000 Nov;109(4):602-15
pubmed: 11195984
J Med Internet Res. 2019 May 13;21(5):e11349
pubmed: 31094331
Emotion. 2020 Jul 27;:
pubmed: 32718175
Stat Med. 2000 Dec 15;19(23):3219-36
pubmed: 11113956
JMIR Ment Health. 2016 Mar 01;3(1):e7
pubmed: 26932350
Psychol Med. 2020 Jan;50(1):11-19
pubmed: 30630555
Lancet. 2012 Mar 17;379(9820):1056-67
pubmed: 22305766
Depress Anxiety. 2013 Sep;30(9):809-21
pubmed: 23596129
Stat Methods Med Res. 2010 Jun;19(3):237-70
pubmed: 19608601
Br J Psychiatry. 2011 Oct;199(4):317-22
pubmed: 21778171
Psychol Med. 2012 Jul;42(7):1359-71
pubmed: 22085757
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Eur J Health Econ. 2018 Jan;19(1):123-152
pubmed: 28303438
Health Policy. 1996 Jul;37(1):53-72
pubmed: 10158943
Trials. 2018 Jul 31;19(1):406
pubmed: 30060763
Behav Res Ther. 2016 Dec;87:170-181
pubmed: 27697671
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
J Med Internet Res. 2015 Jul 08;17(7):e166
pubmed: 26155878
Psychol Med. 2017 Jan;47(2):279-289
pubmed: 27702414
Med Care. 2004 Dec;42(12):1194-201
pubmed: 15550799
J Affect Disord. 2017 Dec 1;223:175-183
pubmed: 28759865
BMJ. 2010 Mar 19;340:c1066
pubmed: 20304934
Trials. 2014 Jul 05;15:267
pubmed: 24996765
Appl Psychol Health Well Being. 2012 Mar;4(1):1-30
pubmed: 26286968
Psychol Sci. 2015 Jun;26(6):784-93
pubmed: 25862544
Health Qual Life Outcomes. 2012 Dec 27;10:156
pubmed: 23270465
Health Qual Life Outcomes. 2007 Nov 27;5:63
pubmed: 18042300
J Child Psychol Psychiatry. 2015 Jul;56(7):723-34
pubmed: 25640876
J Med Internet Res. 2012 Dec 31;15(1):e2
pubmed: 23302475
Perspect Psychol Sci. 2011 Nov;6(6):589-609
pubmed: 26168379
Stat Methods Med Res. 2005 Aug;14(4):369-95
pubmed: 16178138
Perspect Psychol Sci. 2008 Sep;3(5):400-24
pubmed: 26158958
Cochrane Database Syst Rev. 2016 Aug 09;(8):CD003380
pubmed: 27501438
Psychol Assess. 2003 Jun;15(2):173-83
pubmed: 12847777
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
J Med Internet Res. 2011 Dec 31;13(4):e126
pubmed: 22209829
J Adolesc Health. 2016 Oct;59(4):375-7
pubmed: 27664465
J Pers. 1998 Aug;66(4):607-19
pubmed: 9728418
Ann Intern Med. 2010 Jun 1;152(11):726-32
pubmed: 20335313
J Abnorm Child Psychol. 2018 Oct;46(7):1521-1533
pubmed: 29368207
Psychol Med. 2016 Jan;46(1):11-26
pubmed: 26315536
World Psychiatry. 2019 Feb;18(1):97-98
pubmed: 30600619
Lancet. 2015 Apr 11;385(9976):1472-5
pubmed: 25217115